Non-small cell lung cancer

You have access
Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
YUTAKA TAKAHARA, RYUDAI ABE, SUMITO NAGAE, TAKUYA TANAKA, YOKO ISHIGE, IKUYO SHIONOYA, KOUICHI YAMAMURA, MASAFUMI NOJIRI and MASAHARU IGUCHI

Anticancer Research December 2025, 45 (12) 5633-5644; DOI: https://doi.org/10.21873/anticanres.17897
You have access
Impact of Emphysema Severity on Clinicopathological and Molecular Features in Non–small Cell Lung Cancer
YOSHIYUKI YASUURA, TETSUKAN WOO, SHOMA TANAKA, HARUHIKO MASUDA, YOHEI KAMEDA, KENJI INAFUKU and AYA SAITO

Anticancer Research December 2025, 45 (12) 5655-5666; DOI: https://doi.org/10.21873/anticanres.17899
You have access
Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression
AOSA SASADA, HAYATO KAWACHI, TADAAKI YAMADA, TAE HATA, YASUHIRO GOTO, AKIHIKO AMANO, YOSHIKI NEGI, SATOSHI WATANABE, NAOKI FURUYA, TOMOHIRO OBA, TATSUKI IKOMA, AKIRA NAKAO, KEIKO TANIMURA, HIROKAZU TANIGUCHI, AKIHIRO YOSHIMURA, TOMOYA FUKUI, DAIKI MURATA, KYOICHI KAIRA, SHINSUKE SHIOTSU, ASUKA OKADA, YUSUKE CHIHARA, TAKASHI KIJIMA and KOICHI TAKAYAMA

Anticancer Research November 2025, 45 (11) 5045-5057; DOI: https://doi.org/10.21873/anticanres.17845
You have access
Association Between Administration Timing and Efficacy of Nivolumab in Non-small Cell Lung Cancer Treatment
YUKI IWAHASHI, AKIHIRO TAMIYA, TSUNEHIRO TANAKA, MOTOHIRO TAMIYA, AKIHIRO TSUKAGUCHI, YUJI INAGAKI, YOSHIHIKO TANIGUCHI and KYOICHI OKISHIO

Anticancer Research November 2025, 45 (11) 5077-5084; DOI: https://doi.org/10.21873/anticanres.17848
Open Access
Prognostic Impact of PD-1 Polymorphisms in Non-small Cell Lung Cancer Receiving Dendritic Cell Vaccination
MASAHIRO OGASAWARA, MAMIKO MIYASHITA, YUKA YAMAGISHI and SHUICHI OTA

Anticancer Research October 2025, 45 (10) 4295-4304; DOI: https://doi.org/10.21873/anticanres.17780
You have access
Prognostic Impact of ALK Rearrangements in Resected NSCLC: A Systematic Review and Meta-analysis
HAYOUNG SEONG, SOO HAN KIM, MI-HYUN KIM and JUNG SEOP EOM

Anticancer Research October 2025, 45 (10) 4519-4534; DOI: https://doi.org/10.21873/anticanres.17799
You have access
Thorough Lymphadenectomy Impairs Immunotherapy Outcomes for Postoperative Intrathoracic Recurrence of Non-small Cell Lung Cancer
MASAYA AOKI, GO KAMIMURA, YUSEI TSUNEYOSHI, SHOICHIRO MORIZONO, TAKUYA TOKUNAGA, AYA HARADA-TAKEDA, KOKI MAEDA, TOSHIYUKI NAGATA, KOTA KARIATSUMARI and KAZUHIRO UEDA

Anticancer Research September 2025, 45 (9) 3971-3981; DOI: https://doi.org/10.21873/anticanres.17755
You have access
Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer
BHURICHAYA INNETS, SATAPAT RACHA, ZIN ZIN EI, NICHARAT SRIRATANASAK and PITHI CHANVORACHOTE

Anticancer Research July 2025, 45 (7) 3021-3029; DOI: https://doi.org/10.21873/anticanres.17667
You have access
Physalin F Inhibits Cell Viability and Induces Apoptosis in Non-small Cell Lung Cancer Cells
JHY-MING LI, KAO-TAI YANG and CHEAN-PING WU

Anticancer Research July 2025, 45 (7) 3031-3044; DOI: https://doi.org/10.21873/anticanres.17668
You have access
Does Aggressive Versus Less Aggressive Non-operative Treatment of Large and Very Large (≥7 cm) Lung Cancers Matter?
FEDERICO AMPIL, CARLOS PREVIGLIANO, KIM HEATH and AMY BOZEMAN

Anticancer Research April 2025, 45 (4) 1593-1598; DOI: https://doi.org/10.21873/anticanres.17540

Main menu

User menu

Search

Non-small cell lung cancer

Pages